Treatment of Rosai–Dorfman disease with oral bexarotene: a case series

Background: Rosai–Dorfman disease (RDD) is a rare histiocytic proliferative disorder of unknown etiology. The skin is the most frequent extranodal site of RDD involvement and may be the only organ involved. While RDD is an indolent self-limited disease, treatment is needed in patients with extensive...

Full description

Bibliographic Details
Main Authors: Shamir Geller, Klaus Busam, Paul A. Hamlin, Alison J. Moskowitz, Steven M. Horwitz, Patricia L. Myskowski
Format: Article
Language:English
Published: Taylor & Francis Group 2019-07-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2018.1528001